Loading
Liaoning Chengda Biotechnology Co., Ltd. Stock: price and insider trades · China
成大生物
No insider purchase over the last 90 days. The latest, by 李宁, was filed 11 Apr 2023.
Liaoning Chengda Biotechnology Co., Ltd.: what insiders have been doing
Liaoning Chengda Biotechnology Co., Ltd., classified in the Health Care sector, is a listed company. Its insiders report their share dealings to SSE / SZSE (CSRC). Nothing new has been filed by managers of Liaoning Chengda Biotechnology Co., Ltd. in twelve months, the latest record being from 11 April 2023.
Since 2023, the database holds 2 purchases and no sales by insiders of the company.
For comparison within the same sector, see the insider buying recorded at MAIA Biotechnology, Inc. and Cooper Companies, Inc. Every figure here comes from the filings published by SSE / SZSE (CSRC) and describes the past, not future prices; it is not investment advice.
Insider Decl.
2
Thresholds
n/a
Buy Volume
€86,914
2 ops. · all time
Sell Volume
n/a
n/a
Since the insiders bought
- -22.4%Entry CN¥35.87 · Close at T+365 CN¥27.83
- -22.4%Entry CN¥35.87 · Close at T+365 CN¥27.83
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 11,574 of 23,476 companies
51.9
score / 100
Value33
Quality71
FCF yld0.4%
Earn yld1.5%
EV/EBITDA25.0x
ROE0.5%
Gross mgn79%
Net mgn9.5%
Debt/EBITDA0.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
CN¥20.99
Analyst consensus
Income statement
RevenueCN¥1.4B
Gross profitCN¥1.1B79% margin
EBITDACN¥349.6M25% margin
Net incomeCN¥131.8M3.1% margin
Valuation
PER (trailing)209.9x
PER (forward)38.9x
P/Book0.9x
Beta0.42
Balance sheet & cash
Market capCN¥8.7B
Total debtCN¥9.4M
Free Cash FlowCN¥32.8M
Debt / Equity0%
Profitability & ownership
ROE0.5%
ROA-0.1%
% insiders57.6%
% institutions0.5%
Last declaration on 11 April 2023
About Liaoning Chengda Biotechnology Co., Ltd.
成大生物 is a company in the healthcare and pharmaceutical sector, listed on the Shanghai Stock Exchange. It focuses on the research and development of biological and pharmaceutical products.
